InsiderClue
Stocks · Health care · Pharmaceutical Preparations

TAKEDA PHARMACEUTICAL CO LTD

TAK Clue Score36
Japan CIK 0001395064
$18.73 +1.13% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $18.73 +31.72% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue1,732.05Operating income155.87Net income114.94EPS, diluted146.26Fiscal year 2018Revenue1,770.53 +2.2%Operating income241.79Net income186.89 +62.6%EPS, diluted237.56Fiscal year 2019Revenue2,097.22 +18.5%Operating income237.69Net income135.19 −27.7%EPS, diluted139.82Fiscal year 2020Revenue3,291.19 +56.9%Operating income100.41Net income44.24 −67.3%EPS, diluted28.25Fiscal year 2021Revenue3,197.81 −2.8%Operating income509.27Net income376.01 +749.9%EPS, diluted238.96Fiscal year 2022Revenue3,569.01 +11.6%Operating income460.84Net income230.06 −38.8%EPS, diluted145.87Fiscal year 2023Revenue4,027.48 +12.8%Operating income490.51Net income317.02 +37.8%EPS, diluted201.94Fiscal year 2024Revenue4,263.76 +5.9%Operating income214.08Net income144.07 −54.6%EPS, diluted91.16Fiscal year 2025Revenue4,581.55 +7.5%Operating income342.59Net income107.93 −25.1%EPS, diluted67.23
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1,732.05 1,770.53 2,097.22 3,291.19 3,197.81 3,569.01 4,027.48 4,263.76 4,581.55
Growth +2.2% +18.5% +56.9% −2.8% +11.6% +12.8% +5.9% +7.5%
Operating income 155.87 241.79 237.69 100.41 509.27 460.84 490.51 214.08 342.59
Net income 114.94 186.89 135.19 44.24 376.01 230.06 317.02 144.07 107.93
Growth +62.6% −27.7% −67.3% +749.9% −38.8% +37.8% −54.6% −25.1%
EPS, diluted 146.26 237.56 139.82 28.25 238.96 145.87 201.94 91.16 67.23

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin9.0%Net margin6.6%Free cash flow margin11.5%Fiscal year 2018Operating margin13.7%Net margin10.6%Free cash flow margin17.6%Fiscal year 2019Operating margin11.3%Net margin6.4%Free cash flow margin12.0%Fiscal year 2020Operating margin3.1%Net margin1.3%Free cash flow margin16.5%Fiscal year 2021Operating margin15.9%Net margin11.8%Free cash flow margin28.1%Fiscal year 2022Operating margin12.9%Net margin6.4%Free cash flow margin28.0%Fiscal year 2023Operating margin12.2%Net margin7.9%Free cash flow margin20.8%Fiscal year 2024Operating margin5.0%Net margin3.4%Free cash flow margin12.7%Fiscal year 2025Operating margin7.5%Net margin2.4%Free cash flow margin18.7%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 9.0% 13.7% 11.3% 3.1% 15.9% 12.9% 12.2% 5.0% 7.5%
Net margin 6.6% 10.6% 6.4% 1.3% 11.8% 6.4% 7.9% 3.4% 2.4%
Free cash flow margin 11.5% 17.6% 12.0% 16.5% 28.1% 28.0% 20.8% 12.7% 18.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow261.36Capital expenditure−61.66Free cash flow199.70Buybacks−23.12Dividends paid−141.69Fiscal year 2018Operating cash flow377.85Capital expenditure−67.01Free cash flow310.85 +55.7%Buybacks−18.76Dividends paid−141.89Fiscal year 2019Operating cash flow328.48Capital expenditure−77.68Free cash flow250.80 −19.3%Buybacks−1.17Dividends paid−142.95Fiscal year 2020Operating cash flow669.75Capital expenditure−127.08Free cash flow542.67 +116.4%Buybacks−3.74Dividends paid−282.58Fiscal year 2021Operating cash flow1,010.93Capital expenditure−111.21Free cash flow899.73 +65.8%Buybacks−2.14Dividends paid−283.36Fiscal year 2022Operating cash flow1,123.11Capital expenditure−123.25Free cash flow999.85 +11.1%Buybacks−77.53Dividends paid−283.67Fiscal year 2023Operating cash flow977.16Capital expenditure−140.66Free cash flow836.50 −16.3%Buybacks−26.93Dividends paid−279.42Fiscal year 2024Operating cash flow716.34Capital expenditure−175.42Free cash flow540.92 −35.3%Buybacks−2.33Dividends paid−287.19Fiscal year 2025Operating cash flow1,057.18Capital expenditure−200.80Free cash flow856.39 +58.3%Buybacks−51.86Dividends paid−302.50
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 261.36 377.85 328.48 669.75 1,010.93 1,123.11 977.16 716.34 1,057.18
Capital expenditure −61.66 −67.01 −77.68 −127.08 −111.21 −123.25 −140.66 −175.42 −200.80
Free cash flow 199.70 310.85 250.80 542.67 899.73 999.85 836.50 540.92 856.39
Growth +55.7% −19.3% +116.4% +65.8% +11.1% −16.3% −35.3% +58.3%
Buybacks −23.12 −18.76 −1.17 −3.74 −2.14 −77.53 −26.93 −2.33 −51.86
Dividends paid −141.69 −141.89 −142.95 −282.58 −283.36 −283.67 −279.42 −287.19 −302.50

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash319.46Shareholders’ equity1,948.97Fiscal year 2018Cash294.52Total debt985.64Net cash (debt)−691.12Shareholders’ equity1,997.42Debt to equity0.49Fiscal year 2019Cash702.09Total debt4,766.01Net cash (debt)−4,063.91Shareholders’ equity5,181.99Debt to equity0.92Fiscal year 2020Cash637.61Total debt4,506.49Net cash (debt)−3,868.87Shareholders’ equity4,723.48Debt to equity0.95Fiscal year 2021Cash966.22Total debt4,613.22Net cash (debt)−3,647.00Shareholders’ equity5,173.04Debt to equity0.89Fiscal year 2022Cash849.70Total debt4,141.42Net cash (debt)−3,291.72Shareholders’ equity5,683.02Debt to equity0.73Fiscal year 2023Cash533.53Total debt4,042.74Net cash (debt)−3,509.21Shareholders’ equity6,354.12Debt to equity0.64Fiscal year 2024Cash457.80Total debt4,476.50Net cash (debt)−4,018.70Shareholders’ equity7,273.26Debt to equity0.62Fiscal year 2025Cash385.11Total debt3,966.33Net cash (debt)−3,581.21Shareholders’ equity6,935.08Debt to equity0.57
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 319.46 294.52 702.09 637.61 966.22 849.70 533.53 457.80 385.11
Total debt n/a 985.64 4,766.01 4,506.49 4,613.22 4,141.42 4,042.74 4,476.50 3,966.33
Net cash (debt) n/a −691.12 −4,063.91 −3,868.87 −3,647.00 −3,291.72 −3,509.21 −4,018.70 −3,581.21
Shareholders’ equity 1,948.97 1,997.42 5,181.99 4,723.48 5,173.04 5,683.02 6,354.12 7,273.26 6,935.08
Debt to equity n/a 0.49 0.92 0.95 0.89 0.73 0.64 0.62 0.57

In billions of JPY, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Mar 2017 FY2018 31 Mar 2018 FY2019 31 Mar 2019 FY2020 31 Mar 2020 FY2021 31 Mar 2021 FY2022 31 Mar 2022 FY2023 31 Mar 2023 FY2024 31 Mar 2024 FY2025 31 Mar 2025
Margins
9.0% 13.7% 11.3% 3.1% 15.9% 12.9% 12.2% 5.0% 7.5%
8.3% 12.3% 6.1% −1.8% 11.5% 8.5% 9.3% 1.2% 3.8%
6.6% 10.6% 6.4% 1.3% 11.8% 6.4% 7.9% 3.4% 2.4%
11.5% 17.6% 12.0% 16.5% 28.1% 28.0% 20.8% 12.7% 18.7%
Spending
18.0% 18.4% 17.6% 15.0% 14.3% 14.7% 15.7% 17.1% 15.9%
3.6% 3.8% 3.7% 3.9% 3.5% 3.5% 3.5% 4.1% 4.4%
19.4% 14.0% −5.9% n/a −2.7% 23.9% 15.5% −173.1% 38.2%
Returns
5.9% 9.4% 2.6% 0.9% 7.3% 4.0% 5.0% 2.0% 1.6%
n/a 4.6% 1.0% 0.3% 2.9% 1.7% 2.3% 1.0% 0.8%
Balance and payout
n/a 0.49 0.92 0.95 0.89 0.73 0.64 0.62 0.57
n/a 50.9% 62.4% 63.1% 59.9% 56.9% 54.5% 51.9% 51.3%
123.3% 75.9% 105.7% 638.7% 75.4% 123.3% 88.1% 199.3% 280.3%
82.5% 51.7% 57.5% 52.8% 31.7% 36.1% 36.6% 53.5% 41.4%

Shown in JPY as filed; the screener converts to dollars.